Sec. 8107. Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid
167 words·~1 min read·
/bill/115/hr/6/eah/section-8107A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than December 31, 2018, the Secretary of Health and Human Services shall publish in the Federal Register a final notice of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid, based on the notice of proposed mandatory guidelines published in the Federal Register on May 15, 2015 (94 FR 28054). To the extent practicable and consistent with the objective of the testing described in subsection
(a)to detect illegal or unauthorized use of substances by the individual being tested, the final notice of scientific and technical guidelines under that subsection, as determined by the Secretary of Health and Human Services, shall eliminate the risk of positive test results, of the individual being tested, caused solely by the drug use of others and not caused by the drug use of the individual being tested. Nothing in this section may be construed as requiring the Secretary of Health and Human Services to reissue a notice of proposed mandatory guidelines to carry out subsection (a).